NCT07254299 Hypnosis to Improve Well-beings of Critically Ill Patients and Prevent Post-intensive Care Syndrome
| NCT ID | NCT07254299 |
| Status | Recruiting |
| Phase | — |
| Sponsor | COEN Matteo |
| Condition | Post Intensive Care Syndrome (PICS) |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-03-16 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-03-16 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of a hypnosis intervention in improving well-being at day 28 of an ICU stay. The main question it aims to answer is : -Does Hypnosis intervention at ICU discharge and on day 7 and 14 on the wards if the patient remains in the hospital, improve wellbeing at 28 days ? Researchers will compare discharged ICU patients who received standard post-discharge care to discharged ICU patients who received standard post-discharge care and hypnosis intervention on discharge and 7 and 14days after if they are still in the hospital, to see if hypnosis can improve their wellbeing. Participants will receive a hypnosis session on the day of ICU discharge, a second session seven days post-discharge and a third session at day 14 if they are still in the hospital.
Eligibility Criteria
Inclusion Criteria: * On Mechanical Ventilation for at least 2 days * Able to give informed consent as documented by signature * French speaking Exclusion Criteria: * Refusal of the patient * Patient transferred from another ICU * Patient is planned for a withdrawal of care or is actively dying * Glasgow coma scale (GCS) \<15 on ICU discharge * Patient presenting with delirium (detected by CAM-ICU) on ICU discharge * Patient hospitalized for traumatic brain injury * Patient is in jail * Patient hospitalized for more than 28 days in the ICU
Contact & Investigator
Hannah Wozniak, Medical Doctor
PRINCIPAL INVESTIGATOR
University Hospital, Geneva
Frequently Asked Questions
Who can join the NCT07254299 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post Intensive Care Syndrome (PICS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07254299 currently recruiting?
Yes, NCT07254299 is actively recruiting participants. Contact the research team at hannah-wozniak@hug.ch for enrollment information.
Where is the NCT07254299 trial being conducted?
This trial is being conducted at Geneva, Switzerland, Neuchâtel, Switzerland.
Who is sponsoring the NCT07254299 clinical trial?
NCT07254299 is sponsored by COEN Matteo. The principal investigator is Hannah Wozniak, Medical Doctor at University Hospital, Geneva. The trial plans to enroll 150 participants.